Loading
TT
Tobira Therapeutics, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Pentwater Capital Management LP, was filed 02 Nov 2016.
Tobira Therapeutics, Inc.: what insiders have been doing
Tobira Therapeutics, Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). The past year has been quiet: not a single insider filing for Tobira Therapeutics, Inc. The previous disclosure was published on 4 November 2016.
Looking back to 2016, when coverage begins, insiders filed 8 purchases and 10 sales.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
27
Thresholds
n/a
Buy Volume
€3M
8 ops. · all time
Sell Volume
€2M
10 ops. · all time
Last declaration on 4 November 2016
Declarations27 total
38,094 shares@ US$28.35Common StockSEC:0000904454-16-001535:0
1,657 shares@ US$28.35Common StockSEC:0000904454-16-001533:0
3,553,322 shares@ US$28.35Common StockSEC:0000904454-16-001531:0
285,679 shares@ US$28.35Common StockSEC:0000904454-16-001527:0
47,613 shares@ US$28.35Common StockSEC:0000904454-16-001529:0
11 sharesCommon Stock, par value $0.001SEC:0001209191-16-148105:0
5 sharesCommon Stock, par value $0.001SEC:0001209191-16-148105:1
243,726 sharesCommon Stock, par value $0.001SEC:0001209191-16-148108:0
2,668,570 shares@ US$28.35Common StockSEC:0001012975-16-001554:0
10,000 shares@ US$41.71Common Stock, par value $0.001 per shareSEC:0001140361-16-084575:0
Canonical exit: 29 Jan 2017 (T+90)
5,000 shares@ US$42.10Common Stock, par value $0.001 per shareSEC:0001140361-16-084575:1
Canonical exit: 29 Jan 2017 (T+90)
4,300 shares@ US$39.89Common Stock, par value $0.001 per shareSEC:0001140361-16-083089:0
Canonical exit: 15 Jan 2017 (T+90)
27,400 shares@ US$40.10Common Stock, par value $0.001 per shareSEC:0001140361-16-083089:1
Canonical exit: 15 Jan 2017 (T+90)
8,300 shares@ US$40.04Common Stock, par value $0.001 per shareSEC:0001140361-16-083089:2
Canonical exit: 16 Jan 2017 (T+90)
4,481 shares@ US$39.83Common Stock, par value $0.001 per shareSEC:0001140361-16-082173:0
Canonical exit: 2 Jan 2017 (T+90)
6,500 shares@ US$39.49Common Stock, par value $0.001 per shareSEC:0001140361-16-081272:0
Canonical exit: 28 Dec 2016 (T+90)
9,019 shares@ US$39.49Common Stock, par value $0.001 per shareSEC:0001140361-16-081272:1
Canonical exit: 28 Dec 2016 (T+90)
25 of 27 declarations
About Tobira Therapeutics, Inc.
Tobira Therapeutics, Inc. is a biopharmaceutical company focused on developing treatments for liver diseases. It primarily targets therapies for non-alcoholic fatty liver disease and other liver conditions.
